Module 16- T1D Only Flashcards

1
Q

Between 2001 and 2009 there was a … increase in T1D for people under 20

A

21%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Contribution of microbial species to disease

A

Metabolic network + Dynamic equilibrium with themselves and our cells + Innate and acquired defensive systems imbalanced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Kill Beta cells

A

Induced T and B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Proof that microbes play role in T1D

A

Provide antibiotics –> No disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Leaky gut and T1D steps

A

Antigen gets through leaky gut –> activate APC in lamina propria –> cytokine release –> T and B cell activation –> kill beta cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

BB-DR rats

A

Biobreathing drug resistant predisposed to diabetes but do not get it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

BB-DP rats

A

Biobreathing diabetes prone rats that get diabetes between day 17 and 110

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Microbes in BB-DP rats

A

Bacteroides - Xanthomonas + Acinetobacter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

BB-DR rats

A

Lactobacillus- Clostridium, Flexibacter, Porphyromonas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

454-Pyrosequencing

A

Less diverse microbiota in rats over time and less richness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Criteria for selection of microbiota transplant of Lactobacillus

A

From 500 colonies –> Found in humans, probiotic properties reported (tolerance to bile and acid), no antagonistic effect to other Lactobacillus species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Onset of T1D

A

Days 69-110 –> gibe bacteria orally pre-weaning or post-weaing (immediate or after start of solid food) –> only difference in post weaning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

L. Johnsonii changes in microbiota bacterial counts?

A

No differences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

RT-PCR

A

Culture Independent method to see change in microbiota

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

RT-PCR results

A

More Lactobacillus in healthy and Enterococci in diabetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Changes in mucosal integrity/architecture

A

Measure villi and necrosis but saw no differences

17
Q

Tight junctions

A

Claudin (and occludin) higher –> Ljo fed

18
Q

L. johnsonii changes

A

Tight junction proteins and cytokines

19
Q

Cytokines changes by L. johnsonii

A

IFNY (and TNFa); lower expression of pro cytokines

20
Q

Addition of TNF-a to epi cells and look at cytokine production

A

No effect at higher concentrations but does induce immune system by chemokine that prevent later IR

21
Q

L. Johnsonii modulate IR through

A

TLR7 and TL9; mostly through DNA molecules

22
Q

Mech Ljo use to modulate IR

A

Polarizing-tolerizing mechanism

23
Q

TRL9 induction gives

A

Increased paneth cells that secrete AM molecules found at the bottom of crypts –> more secretion of AM molecules

24
Q

Phases of T1D testing

A

Proof of concept –> Phase one on healthy –> Phase two on disease –> phase 3 on kids to prevent onset

25
Placebo
Dried milk
26
Study Design
Baseline --> Ljo N6.2 or placebo --> wash out --> look at blood and stool samples
27
Ljo led to
Significant decrease of symptoms in questionnaire including anxiety and epidermal syndrome
28
Immunotyping of trial
Cell types
29
Cell Types that increased upon supplementation
Monocytes and NK cells and CD8 cells
30
Cell types that were modified
T cell subsets (decreased)
31
CD8 cells...
Start to decrease after wash out
32
Th types activation
Th1 after 8 weeks and Th17 after 12 weeks
33
In healthy subjects Ljo led to more
Circulating IgA
34
Changes in microbiome
Larger between each individual than between treatments
35
Risk of Ljo
None in healthy
36
Ljo suppresses
GI distress syndrome and cephalic syndrome
37
Altered metabolies
Tryptophan pathway metabolites after 12 weeks with increasing LAB over time
38
Th subtype mainly increased
Th1